Hematology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
B-Cell Lymphoma Therapy
Research on B-cell lymphoma therapy described by scientists at University of Pavia, Division of Hematology
April 16th, 2007
Researchers detail in "Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT," new data in B-cell lymphoma. "Hepatitis C virus (HCV) infection is frequently associated with B-cell non-Hodgkin's lymphomas. We investigated the prevalence of HCV infection in nongastric marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT) in order to define the relationship between the viral infection and the presenting features, treatment, and outcome," scientists in Italy report. "We retrospectively studied 172 patients with a histological diagnosis of marginal zone B-cell lymphoma of MALT, except for stomach, and with available HCV serology, among...
Source: Hematology Week (2007-04-16)
|
